Aug 6, 2024, 14:09
DeepHRD predicts HRD from routine biopsy slides
Elvina Almuradova, Medical Oncologist Ambassador at European School of Oncology, shared a post on X, about recent paper published in Journal of Clinical Oncology:
Authors: Erik N. Bergstrom, Ammal Abbasi, Marcos Díaz-Gay, Loïck Galland, Sylvain Ladoire, Scott M. Lippman, Ludmil B. Alexandrov.
”DeepHRD, a new AI tool, predicts homologous recombination deficiency from routine biopsy slides. In studies, it outperformed traditional tests, predicting better outcomes for breast and ovarian cancer patients.”
Source: Elvina Almuradova/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 7, 2024, 00:18
Nov 7, 2024, 00:04
Nov 6, 2024, 18:17